Sintecabio ranked among the top searched stocks for 2 days in the past month.


As of 1:30 PM on the 7th, Sintecabio is trading at 24,750 KRW, up 1.02% from the previous day. This marks a 105.39% increase compared to August 18. Sintecabio is known as a genomic big data research company.

Today, foreigners are tentatively recorded as net sellers of 2,000 shares. Over the past 5 days, individual investors have net bought 129,080 shares, while foreigners and institutions have net sold 124,528 shares and 1,077 shares, respectively.


On September 4, Sintecabio became an issue in the market with the headline "'16%↑ treatment rate higher than Remdesivir'."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing